FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2024656270> ?p ?o ?g. }

• W2024656270 endingPage "417" @default.
• W2024656270 startingPage "412" @default.
• W2024656270 abstract "Glucocorticoids (GCs) are regarded as diabetogenic because they impair insulin sensitivity and islet-cell function. This study assessed whether treatment with the glucagon-like peptide receptor agonist (GLP-1 RA) exenatide (EXE) could prevent GC-induced glucose intolerance.A randomized, placebo-controlled, double-blind, crossover study in eight healthy men (age: 23.5 [20.0-28.3] years; BMI: 26.4 [24.3-28.0] kg/m(2)) was conducted. Participants received three therapeutic regimens for 2 consecutive days: 1) 80 mg of oral prednisolone (PRED) every day (q.d.) and intravenous (IV) EXE infusion (PRED+EXE); 2) 80 mg of oral PRED q.d. and IV saline infusion (PRED+SAL); and 3) oral placebo-PRED q.d. and intravenous saline infusion (PLB+SAL). On day 1, glucose tolerance was assessed during a meal challenge test. On day 2, participants underwent a clamp procedure to measure insulin secretion and insulin sensitivity.PRED+SAL treatment increased postprandial glucose levels (vs. PLB+SAL, P = 0.012), which was prevented by concomitant EXE (vs. PLB+SAL, P = NS). EXE reduced PRED-induced hyperglucagonemia during the meal challenge (P = 0.018) and decreased gastric emptying (vs. PRED+SAL, P = 0.028; vs. PLB+SAL, P = 0.046). PRED+SAL decreased first-phase glucose- and arginine-stimulated C-peptide secretion (vs. PLB+SAL, P = 0.017 and P = 0.05, respectively), whereas PRED+EXE improved first- and second-phase glucose- and arginine-stimulated C-peptide secretion (vs. PLB+SAL; P = 0.017, 0.012, and 0.093, respectively).The GLP-1 RA EXE prevented PRED-induced glucose intolerance and islet-cell dysfunction in healthy humans. Incretin-based therapies should be explored as a potential strategy to prevent steroid diabetes." @default.
• W2024656270 created "2016-06-24" @default.
• W2024656270 creator A5025621864 @default.
• W2024656270 creator A5029349104 @default.
• W2024656270 creator A5067127165 @default.
• W2024656270 creator A5068474395 @default.
• W2024656270 creator A5086867925 @default.
• W2024656270 date "2011-01-20" @default.
• W2024656270 modified "2023-09-27" @default.
• W2024656270 title "Glucagon-Like Peptide-1 Receptor Agonist Treatment Prevents Glucocorticoid-Induced Glucose Intolerance and Islet-Cell Dysfunction in Humans" @default.
• W2024656270 cites W1966372003 @default.
• W2024656270 cites W1974022347 @default.
• W2024656270 cites W1975125324 @default.
• W2024656270 cites W1989091317 @default.
• W2024656270 cites W2019566854 @default.
• W2024656270 cites W2021473664 @default.
• W2024656270 cites W2035409850 @default.
• W2024656270 cites W2044957767 @default.
• W2024656270 cites W2047680032 @default.
• W2024656270 cites W2057624928 @default.
• W2024656270 cites W2061390926 @default.
• W2024656270 cites W2070710390 @default.
• W2024656270 cites W2084948079 @default.
• W2024656270 cites W2091830937 @default.
• W2024656270 cites W2101613382 @default.
• W2024656270 cites W2105803008 @default.
• W2024656270 cites W2115707749 @default.
• W2024656270 cites W2119513121 @default.
• W2024656270 cites W2121558006 @default.
• W2024656270 cites W2148798434 @default.
• W2024656270 cites W2155881904 @default.
• W2024656270 cites W2157869836 @default.
• W2024656270 cites W2161163854 @default.
• W2024656270 cites W2171303876 @default.
• W2024656270 doi "https://doi.org/10.2337/dc10-1677" @default.
• W2024656270 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3024359" @default.
• W2024656270 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21216851" @default.
• W2024656270 hasPublicationYear "2011" @default.
• W2024656270 type Work @default.
• W2024656270 sameAs 2024656270 @default.
• W2024656270 citedByCount "116" @default.
• W2024656270 countsByYear W20246562702012 @default.
• W2024656270 countsByYear W20246562702013 @default.
• W2024656270 countsByYear W20246562702014 @default.
• W2024656270 countsByYear W20246562702015 @default.
• W2024656270 countsByYear W20246562702016 @default.
• W2024656270 countsByYear W20246562702017 @default.
• W2024656270 countsByYear W20246562702018 @default.
• W2024656270 countsByYear W20246562702019 @default.
• W2024656270 countsByYear W20246562702020 @default.
• W2024656270 countsByYear W20246562702021 @default.
• W2024656270 countsByYear W20246562702022 @default.
• W2024656270 countsByYear W20246562702023 @default.
• W2024656270 crossrefType "journal-article" @default.
• W2024656270 hasAuthorship W2024656270A5025621864 @default.
• W2024656270 hasAuthorship W2024656270A5029349104 @default.
• W2024656270 hasAuthorship W2024656270A5067127165 @default.
• W2024656270 hasAuthorship W2024656270A5068474395 @default.
• W2024656270 hasAuthorship W2024656270A5086867925 @default.
• W2024656270 hasBestOaLocation W20246562701 @default.
• W2024656270 hasConcept C126322002 @default.
• W2024656270 hasConcept C134018914 @default.
• W2024656270 hasConcept C142724271 @default.
• W2024656270 hasConcept C204787440 @default.
• W2024656270 hasConcept C27081682 @default.
• W2024656270 hasConcept C2777180221 @default.
• W2024656270 hasConcept C2778199505 @default.
• W2024656270 hasConcept C2778563252 @default.
• W2024656270 hasConcept C2779306644 @default.
• W2024656270 hasConcept C2779422922 @default.
• W2024656270 hasConcept C2780533449 @default.
• W2024656270 hasConcept C2780841215 @default.
• W2024656270 hasConcept C3020479747 @default.
• W2024656270 hasConcept C555293320 @default.
• W2024656270 hasConcept C71924100 @default.
• W2024656270 hasConcept C87813604 @default.
• W2024656270 hasConceptScore W2024656270C126322002 @default.
• W2024656270 hasConceptScore W2024656270C134018914 @default.
• W2024656270 hasConceptScore W2024656270C142724271 @default.
• W2024656270 hasConceptScore W2024656270C204787440 @default.
• W2024656270 hasConceptScore W2024656270C27081682 @default.
• W2024656270 hasConceptScore W2024656270C2777180221 @default.
• W2024656270 hasConceptScore W2024656270C2778199505 @default.
• W2024656270 hasConceptScore W2024656270C2778563252 @default.
• W2024656270 hasConceptScore W2024656270C2779306644 @default.
• W2024656270 hasConceptScore W2024656270C2779422922 @default.
• W2024656270 hasConceptScore W2024656270C2780533449 @default.
• W2024656270 hasConceptScore W2024656270C2780841215 @default.
• W2024656270 hasConceptScore W2024656270C3020479747 @default.
• W2024656270 hasConceptScore W2024656270C555293320 @default.
• W2024656270 hasConceptScore W2024656270C71924100 @default.
• W2024656270 hasConceptScore W2024656270C87813604 @default.
• W2024656270 hasIssue "2" @default.
• W2024656270 hasLocation W20246562701 @default.
• W2024656270 hasLocation W20246562702 @default.
• W2024656270 hasLocation W20246562703 @default.
• W2024656270 hasLocation W20246562704 @default.
• W2024656270 hasOpenAccess W2024656270 @default.

• next